BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

HemaQuest 

233 Needham Street
Suite 300
Newton  Massachusetts  02464  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





 Company News
HemaQuest Completes Patient Enrollment in Phase 2b Clinical Study of HQK-1001 in Patients With Sickle Cell Disease 6/10/2013 10:31:39 AM    More...
HemaQuest Raises $13 Million in Series B Extension Financing 3/12/2012 7:21:34 AM    More...
HemaQuest Completes Patient Enrollment in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease 9/12/2011 11:18:04 AM    More...
HemaQuest Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease 4/26/2011 8:45:39 AM    More...
HemaQuest Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology 12/7/2010 7:33:46 AM    More...
HemaQuest Announces John P. Longenecker, Ph.D. to Serve as President and CEO; Company Establishes Headquarters in San Diego 12/3/2010 6:49:12 AM    More...
HemaQuest Names New CEO 11/17/2010 7:56:50 AM    More...
HemaQuest Initiates Phase 2 Clinical Trial in EBV-Related Malignancies 8/11/2010 8:16:00 AM    More...
HemaQuest Raises $4M More, Boosting VC Round to $16M for Sickle Cell, Blood Disorders 7/28/2010 7:18:57 AM    More...
HemaQuest Secures $12 Million to Advance Clinical Programs 4/21/2010 6:24:45 AM    More...
12

//-->